Bank Of Nova Scotia Charles River Laboratories International, Inc. Transaction History

Bank Of Nova Scotia

$39.9 Billion
Q1 2025

A detailed history of Bank Of Nova Scotia transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bank Of Nova Scotia holds 1,855 shares of CRL stock, worth $252,743. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,855

Previous 5,011 62.98%

Holding current value

$252,743

Previous $925,000 69.84%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$150.52 - $190.14 $475,041 - $600,081	-3,156 Reduced 62.98%	1,855 $279,000
Q4 2024 Feb 13, 2025	BUY	$178.58 - $220.69 $41,430 - $51,200	232 Added 4.85%	5,011 $925,000
Q3 2024 Nov 13, 2024	BUY	$187.96 - $245.29 $327,802 - $427,785	1,744 Added 57.46%	4,779 $941,000
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $425,163 - $553,583	-2,060 Reduced 40.43%	3,035 $626,000
Q1 2024 May 14, 2024	BUY	$203.52 - $273.43 $147,959 - $198,783	727 Added 16.64%	5,095 $1.38 Million
Q4 2023 Feb 12, 2024	BUY	$164.52 - $238.84 $285,277 - $414,148	1,734 Added 65.83%	4,368 $1.03 Million
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $99,747 - $111,633	513 Added 24.19%	2,634 $516,000
Q2 2023 Aug 03, 2023	SELL	$183.71 - $210.25 $257,561 - $294,770	-1,402 Reduced 39.8%	2,121 $445,000
Q1 2023 May 11, 2023	SELL	$191.89 - $259.92 $119,739 - $162,190	-624 Reduced 15.05%	3,523 $711,000
Q4 2022 Feb 09, 2023	SELL	$197.11 - $250.07 $7,884 - $10,002	-40 Reduced 0.96%	4,147 $903,000
Q3 2022 Nov 10, 2022	BUY	$182.44 - $250.54 $364 - $501	2 Added 0.05%	4,187 $824,000
Q2 2022 Aug 05, 2022	SELL	$204.13 - $302.4 $7.55 Million - $11.2 Million	-36,991 Reduced 89.84%	4,185 $896,000
Q1 2022 May 09, 2022	BUY	$255.51 - $362.11 $8.07 Million - $11.4 Million	31,585 Added 329.32%	41,176 $11.7 Million
Q4 2021 Feb 11, 2022	BUY	$351.38 - $448.68 $417,439 - $533,031	1,188 Added 14.14%	9,591 $3.62 Million
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $261,965 - $322,184	703 Added 9.13%	8,403 $3.47 Million
Q2 2021 Aug 12, 2021	BUY	$294.17 - $371.65 $2.27 Million - $2.86 Million	7,700 New	7,700 $2.85 Million

Others Institutions Holding CRL

# of Institutions

649

Shares Held

55M

Call Options Held

695K

Put Options Held

809K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $6.93B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.

Account

Bank Of Nova Scotia Charles River Laboratories International, Inc. Transaction History